Analysis of growth factor signaling in genetically diverse breast cancer lines
about
IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy ResistanceSystems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).A global microRNA screen identifies regulators of the ErbB receptor signaling network.Interferon α/β Enhances the Cytotoxic Response of MEK Inhibition in Melanoma.MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyMolecular mechanism matters: Benefits of mechanistic computational models for drug development.Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation.Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.Quantification of growth factor signaling and pathway cross talk by live-cell imaging.Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells.An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer.Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions.Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens.Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition.
P2860
Q26802042-A71F98C6-D7E8-4676-9DCF-98410481A9A4Q33917876-17C36CD3-B78E-4416-ABB0-9CDF5603862BQ35041481-D0BCF337-CBE7-43A3-9095-8BDD7D844C0AQ35164197-B4660C86-35AF-4A48-A1EE-B825BFE56A4AQ35834882-20C60843-AE49-46FA-BA3B-49A9AF7D227EQ36052870-5114EB59-0216-4218-8251-924108FEF6A5Q36111215-41D2A607-E2A1-45B6-B8E8-CFC7904E7566Q36236932-38102F52-22C5-4486-AEFA-3B186C7E75A1Q37626301-FE99A4B6-4532-450E-AD3A-CCFFCC01E3ACQ38720684-266A07C8-BFA8-4BB1-A536-18CC89862C5EQ38869026-528C7DFE-9752-4E86-B161-7189C8778C4EQ38948857-AB5A8A7E-7163-4F77-83F6-4835083882CDQ42331869-D2450212-6862-457B-B787-76205C32EFA3Q43635406-C7F5B28C-EE5C-4A9E-85B9-45BB834AD337Q52631151-F6BCD87D-4E05-4279-B648-89AB0CD58CDDQ52671165-AEEE41FD-BEBD-4925-8A78-B54761B24EA1
P2860
Analysis of growth factor signaling in genetically diverse breast cancer lines
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Analysis of growth factor signaling in genetically diverse breast cancer lines
@ast
Analysis of growth factor signaling in genetically diverse breast cancer lines
@en
Analysis of growth factor signaling in genetically diverse breast cancer lines
@nl
type
label
Analysis of growth factor signaling in genetically diverse breast cancer lines
@ast
Analysis of growth factor signaling in genetically diverse breast cancer lines
@en
Analysis of growth factor signaling in genetically diverse breast cancer lines
@nl
prefLabel
Analysis of growth factor signaling in genetically diverse breast cancer lines
@ast
Analysis of growth factor signaling in genetically diverse breast cancer lines
@en
Analysis of growth factor signaling in genetically diverse breast cancer lines
@nl
P2093
P2860
P50
P356
P1433
P1476
Analysis of growth factor signaling in genetically diverse breast cancer lines
@en
P2093
Birgit Schoeberl
Diana H Chai
Emily A Pace
Jeremy L Muhlich
Mirra Chung
P2860
P2888
P356
10.1186/1741-7007-12-20
P577
2014-03-21T00:00:00Z
P5875
P6179
1005287113